Videos

Jake Glaser explains the challenges faced when fundraising for AIDS programs in the 21st century.

Dr. Richard Vickers explains how antibiotics to treat Clostridium difficile infection cause collateral damage to the gut microbiome.

William Schaffner, MD, addresses common misconceptions regarding the influenza vaccine.

Michael Edmond, MD, MPH, MPA, explains how strategies are developed to address different threats in health care settings.

Edmond Hooker, MD, DrPH, discusses the reasons behind why hospital rooms are not being disinfected properly.

Jake Glaser shares who he feels is going to end the AIDS epidemic.

Jake Glaser shares what is needed to achieve the Fast-Track strategy to end the AIDS epidemic by 2030.

Richard Haupt, MD, MPH, explains how a vaccine can serve as a primary prevention modality against C. difficile.

Daniel Diekema, MD, discusses the different roles that clinical laboratories play in outbreak response.

William Schaffner, MD, offers insight into the 2017-2018 flu season, including which strain of the virus that is expected to be most prevalent.

Leonard Sigal, MD, discusses different causes of persisting symptoms after Lyme disease infection.

Richard Haupt, MD, MPH, explains why a vaccine to help prevent C. difficile is so needed.

Michael Edmond, MD, MPH, MPA, explains how health care facilities can work on preparing for the unexpected in the realm of infectious diseases.

Edmond Hooker, MD, DrPH, explains why hospital mattresses are harder to disinfect than other harder surfaces.

Daniel Diekema, MD, explains why microbiology labs should be seen as an integral part of antimicrobial stewardship efforts.

James S. Lewis, PharmD, FIDSA, discusses the role vaccination plays in reducing unnecessary antibiotic use.

William Schaffner, MD, lists some of the common reasons behind why individuals decide against getting their flu shots, and why they should reconsider.

Robert Bransfield, MD, DLFAPA, explains how he was able to establish a correlation between suicidal risk and Lyme disease.

Richard Haupt, MD, MPH, explains the risk factors for Clostridium difficile infection.

Paul Feuerstadt, MD, sheds light on the estimated burden of C. difficile infection in the United States.

Norman B. Javitt, MD, PhD, explains how antibiotics can impact bile acid composition and result in Clostridium difficile infection.

Barley Chironda, RPN, CIC, discusses current infection control measures taken to prevent C. difficile and the reasons why they are falling short.

Joe Sliman, MD, MPH, explains how antibiotics affect the gut microbiome.

Glenn Tillotson, PhD, FIDSA, discusses the societal value of antibiotics.

Sahil Khanna, MBBS, MS, provides a brief overview of the history of fecal microbiota transplantation.

Stuart Johnson, MD, discusses the disadvantages to some of the current approaches used to treat C. difficile.

James S. Lewis, PharmD, FIDSA, explains how pharmacists can advocate for judicious antibiotic use in patients through educating the patients themselves, as well as providers.

Ferric Fang, MD, explains the major challenges associated with diagnosing Clostridium difficile infection.

Roy F. Chemaly, MD, MPH, discusses the background behind letermovir and what it brings to the table.

Dale N. Gerding, MD, discusses different methods used to prevent CDI recurrence.